Core Insights - Smith & Nephew reported Q3 results that align with expectations, supporting full-year guidance for revenue growth and trading margin [2] - Underlying revenue growth for the quarter was 5%, driven by momentum in Sports Medicine and Advanced Wound Management [3] - Orthopaedics growth showed trends similar to the previous quarter, with strong performance in Hips in the U.S. offsetting softer Knee sales [3] Revenue Performance - The strongest Q3 for core Replacements was recorded globally, with significant growth in Trauma and Extremities [3] - Excluding China, underlying revenue growth was 6.4%, indicating a balanced growth across geographies as headwinds in China begin to ease [4]